Both in Biotechnology
Lexeo Therapeutics vs Fate Therapeutics
Over the past year LXEO returned −65.6% and FATE returned +61.9%; their daily moves had a correlation of 0.27.
LXEO −65.6% FATE +61.9%Growth of $1, one year, split-adjusted
| Metric | LXEO | FATE |
|---|---|---|
| Price | $3.11 | $2.04 |
| Market cap | $255.3M | $244.4M |
| Today | +1.63% | +1.49% |
| 1 month | −8.8% | −16.0% |
| 6 months | −47.8% | −13.6% |
| Year to date | −68.7% | +107.6% |
| 1 year | −68.9% | +51.1% |
| Revenue growth (YoY) | — | +9.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 37.7× |
| Net cash | $211.1M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 69.1% | 56.1% |
| Short % of float | 22.9% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).